The promise of minocycline as a potential treatment for multiple sclerosis dimmed a bit on the news that an amyotrophic lateral sclerosis (ALS) trial using the drug  saw patients progression accelerate.

The US researchers who conducted the study warned the Canadian team preparing a trial of the commonly prescribed acne drug for multiple sclerosis. ( Trial reported on in earlier post. ) The Canadian scientists plan to proceed with the trial.